isign investor deck (public) - 2016.09 - v05 (benchmark)

Signed, Sealed, Delivered®

Company Presentation Q3 2016

© 2016 www.isignnow.com

2Notes

This Presentation (the “Presentation”) has been prepared by iSign Solutions Inc. (the "Company") for informational purposes only. The information contained herein has been prepared solely to facilitate an understanding of the Company and its prospects and does not purport to contain all of the information that a party may desire. The Company makes no representation or warranty as to the accuracy or completeness of this Presentation, including any projections or statements about the prospects of the Company, and shall have no liability for any representations (expressed or implied) contained in, or for any omissions from, this Presentation. This Presentation includes forward-looking statements. All statements made in this Presentation that are not of a historical nature, including statements regarding our efforts to develop and commercialize our products, our short-term and long-term business strategies, market and industry expectations and future results of operations and financial position, are forward-looking statements. These forward-looking statements reflect the Company’s current expectations, estimates and predictions about

future results and events. Such projections and statements are based upon assumptions about future events that are inherently uncertain and subjective. Although the Company believes that the expectations contained in these forward-looking statements are reasonable, it cannot give any assurance that these expectations will prove to be correct. Actual results may vary materially from those described in the forward-looking statements. The Company has described in the “Risk Factors” section of the prospectus for its recent offering and elsewhere in its filings withe the Securities and Exchange Commission, the material risks and uncertainties that it believes could cause actual results to differ from the forward-looking statements. The Company is under no duty to update any of the forward-looking statements after the date of this Presentation or to conform these statements to actual results. Nothing contained herein is intended to be, nor should be relied upon as, a promise or representation as to future performance of the Company.

If you have questions relating to this Presentation, you should direct your questions to the Company’s CEO, COO and/or CFO.


About iSIGN

Leading supplier of e-signature and related software solutions

Disruptive technology enabling paperless contract management

Processed billions of secure, fast and cost-effective transactions

Significant market opportunities, sector and valuation growth ahead

3


4Partners and End-Users

Trusted by leading companies to securely process tens of millions of annual transactions


5Meet Our Team

Will Keiper President and COO

JOINED 2011

YEARS 30+

AFFILIATIONS FirstGlobal, Hypercom, JDA, Artisoft, etc.

Nhan Nguyen PhD CTO

JOINED 2010

YEARS 20+

AFFILIATIONS Pay by Touch, Yodlee, iPin, BofA, TRW, etc.

Andrea Goren CFO, Director

JOINED 2010

YEARS 20+

AFFILIATIONS Phoenix, Xplore, Shamrock, MadCap, Disney

Philip Sassower Co-Chairman and CEO

JOINED 2010

YEARS 40+

AFFILIATIONS Phoenix Group, Xplore, Newpark, Bates, etc.

Robert Williams VP Sales

JOINED 2016

YEARS 20+

AFFILIATIONS Interlink, Office Depot, VeraFirma, REN-PaidByCash


6

Digital Transaction Management (DTM)

✓Intersection of electronic signature and paperless document management

✓Improves key business process workflows across the enterprise

✓Sector opportunity: $2 billion today; $30 billion by year-end 20201

Business Sector

1 Aragon Research Tech Spectrum™ For Digital Transaction Management, 2015.

6


7

“A paper form that requires a customer signature costs us more than $35 to

process; the same form signed with an e-signature costs less than $1…”

Charlie Turri AGLA/AIG

30%

reduction in submission

errors

Key E-signature Drivers

50%

or 14 day reduction in quote

to close time

40%

reduction in mailing, postage, scanning

and rekeying

20%

increase in cross/up-selling time

availability

63%

achieved ROI in under 12

months

Sources: Forrester, Gartner, Novarica, Cellent, Aberdeen Research + AIIM.

Sample results published by leading

research firms

33%

reduction in

cycle times


8Sector Validation

has acquired

• DocuSign has attracted significant capital and is believed to be on track for IPO

➡ Raised ~$508M since 2003; latest round valuation of $3B (2015)

➡ Investors include Kleiner Perkins, Accel, Google, VISA, Salesforce, Samsung, Intel…

• M&A aimed at integrating e-signature into acquirers’ existing software offerings

July2011 July2013 September2014

has acquired has acquired

September2014

has acquired

December2015

has acquired

Selected Transactions


9Value and Differentiation 9

Cloud and on-premise

Plug-and-play customization

Low infrastructure cost

Low selling cost (“one-to-many”)

Aggressive, flexible pricing

First-mover advantage in EU

Metric

Cloud ✔ ✔ ✔

On-premise ✔

Customization ✔

Infrastructure AWS Own Own

Sales modelPartner/

DirectDirect/Partner

Direct

Client TCO $ $$$ $$

PAPER-BASED PROCESSES REMAIN OUR PRINCIPAL COMPETITOR


Growth Platform

Completed development of state-of- the-art electronic signature and DTM software platform

Launched SaaS offering on cutting edge Cloud infrastructure

Established software partner integration approach for “one sale = access to many customers”

Set path to profitability from existing partner-client shared revenue

10


11

Key Facts and Figures

Employees / countries 3,600+ / 11

Revenue / EBITDA €426M / €79M

Digital flows managed/year 550M

Health Ins./HR/E-Service Electronic invoicing

IT services/payment flows#1 in EU (300M+)

#1 in FR (40M ppl. covered)

Healthcare Professionals Doctors & paramedics

Pharmacists

#1 in FR, UK, I, E 237,000* 83,000*

* Workstations.

EU public company (EPA: CGM)

iSIGN integrated with Cegedim software platforms for electronic signatures, invoices and payments

Cegedim customers in production today: pharma/healthcare, real estate, financial services, insurance, software services, etc.

Per-transaction recurring revenue share

Exclusive 5-year agreement

Cegedim


12Cegedim Opportunity

Cegedim is the DocuSign of France and an aggressive DTM first-mover in Europe

Large client base, cutting-edge tech and a significant sales and support infrastructure

Rapidly growing EU DTM/e-sign market that trails US by several years

Strong regulatory support incentivizing and mandating paperless transactions

iSIGN has minimal ongoing support costs; bulk of investment complete

iSIGN gross margins expected to exceed 95% on future revenue

Cegedim contributes all sales, marketing, support and infrastructure costs

Leading the way for SaaS solutions charged on a per-transaction basis

Market Positioning Partnership


13Development Stage Revenue

$0

$425

$850

$1,275

$1,700

2013 2014 2015

$1,620$1,515$1,418

(in thousands)

Current OPEX

$2.8M

Revenue to B/E

$1.2M

Assuming 2016 revenue equals 2015 revenue.


14Global Opportunity to Replicate Cegedim

1

2

3

Utilize partner or AWS data centers only – limited infrastructure investment.

SaaS-on-Steroids DTM • Channel partner ISVs • Direct to FSIs & others

North America

SaaS-on-Steroids DTM • Channel partner ISVs

Latin America

• Saas-on-Steroids DTM • Payments

Europe


Business Summary

Development stage complete

Priority shift toward sales and marketing

“One-to-many” (partner) go-to-market approach

Cegedim shared revenue: high-margin model

Cloud & on-premise deployments w/customization

Lower cost structure: incremental revenue drops mostly to bottom line

NOL provides profit leverage

15


16Business Plan Timeline

Complete Current Future

Completed state-of-the-art DTM software platform

Maintain cutting edge platformDrive revenue growth

organically and/or via M&A

Launched SaaS offeringAdd client-requested

functionality (PKI, offline, etc.) Judiciously expand overhead

to support revenue growth

Pivoted sales approach from direct to partner

Focus resources on ensuring prompt Cegedim ramp

Replicate Cegedim model

Pivoted licensing model from one-time to recurring

Curtail costs until cash flow break-even is secured

Expand IR activities


17

Security Pro Forma Notes

Outstanding 5,498,246 As of August 15, 2016

Convertible notes 263,736 $240,000 in unsecured promissory notes

Total shares 5,761,982

Options 553,000 As of August 15, 2016 with an average exercise price was $1.74

Warrants 1,756,000 As of June 30, 2016, with an average exercise price was $5.27

Current Capitalization


18

Q&A

isign investor deck (public) - 2016.09 - v05 (benchmark)

Documents